+ Filter



HIV-1 vpu

Anti-HIV-1 vpu Products
-
- Species Reactivity: HIV-1
- Type: Mouse IgG1
- Application: ELISA
- Mouse Anti-HIV-1 vpu Recombinant Antibody (clone DE7); scFv Fragment (MRO-4331CQ-S(P))
-
- Species Reactivity: HIV-1
- Type: Mouse scFv
- Application: ELISA
- Mouse Anti-HIV-1 vpu Recombinant Antibody (clone DE7); Fab Fragment (MRO-4331CQ-F(E))
-
- Species Reactivity: HIV-1
- Type: Mouse Fab
- Application: ELISA
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Enhances virion budding by targeting host CD4 and Tetherin/BST2 to proteasome degradation. Degradation of CD4 prevents any unwanted premature interactions between viral Env and its host receptor CD4 in the endoplasmic reticulum. Degradation of antiretroviral protein Tetherin/BST2 is important for virion budding, as BST2 tethers new viral particles to the host cell membrane. Mechanistically, Vpu bridges either CD4 or BST2 to BTRC, a substrate recognition subunit of the Skp1/Cullin/F-box protein E3 ubiquitin ligase, induces their ubiquitination and subsequent proteasomal degradation. The alteration of the E3 ligase specificity by Vpu seems to promote the degradation of host IKBKB, leading to NF-kappa-B down-regulation and subsequent apoptosis. Ion channel activity has also been suggested, however, formation of cation-selective channel has been reconstituted ex-vivo in lipid bilayers. It is thus unsure that this activity plays a role in vivo.